Welcome to LookChem.com Sign In|Join Free
  • or
NORGESTIMATE RELATED COMPOUND A (25 MG) (LEVONORGESTREL ACETATE) is a synthetic progestational hormone that is commonly used in the pharmaceutical industry. It is an impurity of Norgestrel, which is a progestational and ovulation inhibiting steroid. Levonorgestrel acetate plays a crucial role in various contraceptive products and hormone replacement therapies.

13732-69-9

Post Buying Request

13732-69-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13732-69-9 Usage

Uses

Used in Pharmaceutical Industry:
NORGESTIMATE RELATED COMPOUND A (25 MG) (LEVONORGESTREL ACETATE) is used as an active pharmaceutical ingredient for the development of contraceptive products, such as birth control pills and emergency contraceptive pills. It helps in preventing ovulation and thickening the cervical mucus, making it difficult for sperm to reach the egg.
Additionally, NORGESTIMATE RELATED COMPOUND A (25 MG) (LEVONORGESTREL ACETATE) is used as a component in hormone replacement therapy for women experiencing menopausal symptoms. It helps in regulating the hormonal balance and alleviating symptoms such as hot flashes and mood swings.

Check Digit Verification of cas no

The CAS Registry Mumber 13732-69-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,7,3 and 2 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 13732-69:
(7*1)+(6*3)+(5*7)+(4*3)+(3*2)+(2*6)+(1*9)=99
99 % 10 = 9
So 13732-69-9 is a valid CAS Registry Number.

13732-69-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-3-oxo-2,3,6,7,8,9,10, 11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-1 7-yl acetate (non-preferred name)

1.2 Other means of identification

Product number -
Other names Levonorgestrel acetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13732-69-9 SDS

13732-69-9Downstream Products

13732-69-9Relevant academic research and scientific papers

PROCESS FOR THE SYNTHESIS OF HIGH PURITY D-(17ALPHA)-13-ETHYL-17-HYDROXY-18,19-DINORPRE:GN-4-ENE-20-YNE-3-ONE-OXIME

-

Page/Page column 4, (2008/06/13)

The invention relates to a process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yne-3-one-oxime (further on norelgestromine) via acetylation of d-norgestrel at position 17, oximation of the oxo group at position 3 of the obtained 17-acetoxy derivative, and finally hydrolyzing the acetoxy group at position 17 of the obtained 3-oxime derivative. The process according to our invention is as follows: the starting material, d-(17α-17-hydroxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one (d-norgestrel) - purity 93-94 % - is acetylated with acetic anhydride in acetic acid, in the presence of zinc chloride and hydrogen chloride, or 70 % perchloric acid in an inert gas atmosphere, and after completion of the reaction the excess of acetic anhydride and the "enol acetate" by-product are decomposed with aqueous hydrochioric acid, then the formed d-(17α)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one is isolated from the reaction mixture by addition of ice-water, the precipitated product is filtered off, washed with water, dried, dissolved in dichloromethane or acetone and clarified with silica gel or aluminum oxide and charcoal, after filtration of the clarifier the resulted solution is concentrated and the residue is recrystallized, the obtained d-(17α)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one is reacted either with hydroxylammonium acetate or with hydroxylammonium chloride in the presence of sodium acetate, in acetic acid in nitrogen atmosphere under vigorous stirring for about 1 hour, after completion of the reaction water is added, the precipitated product is filtered off, washed with water, dried and recrystallized, the obtained d-(17α-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one-oxime is hydrolyzed with an equivalent amount of an alkali metal hydroxide in a C1-C4 alkanol solution, in nitrogen atmosphere between a temperature of about 5-38 °C, under vigorous stirring, after completion of the reaction the mixture is diluted with water and the pH of the resulted suspension is adjusted to 7,5-9 with acetic acid, the precipitated product is filtered off, washed with water, dried, the crude product is dissolved in ethanol, clarified with charcoal, and after filtration of the clarifier water is added to the obtained solution, the precipitated high purity d-(17α)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one-oxime is filtered off, washed with water and in given case recrystallized from ethanol.

3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method

-

, (2008/06/13)

3-Oximes of D-17α-ethynyl-19-nortestosterone esters and derivatives thereof have pre- and post-coital activity for the suppression of fertility.

Synthesis of gon-4-enes

-

, (2008/06/13)

1. A therapeutic composition having progestational activity comprising as active ingredient a 17-aliphatic carboxylic acid ester of 17α-ethynyl-18-methyl-19-nortestosterone and a pharmaceutical carrier for said compound.

Mono-acylation of 17-hydroxy-3-alkoxygona-2,5-(10)dienes

-

, (2008/06/13)

An efficient, one-step process for preparing 13-alkyl-17α alkyl, alkenyl, or alkynyl-17β-acyloxy-4-en-3-one steroids from their corresponding 13-alkyl-17α-substituted-3-alkoxygona-2,5(10)-dien-17β-ols is disclosed. Products of the instant process possess, for example, progestational activity.

Synthesis of 13-alkyl-gon-4-ones

-

, (2008/06/13)

The preparation of 13-methylgon-4-enes and novel 13-polycarbonalkylgon-4-enes by a new total synthesis is described. 13-Alkylgon-4-enes having progestational, anabolic and androgenic activities are prepared by forming a tetracylic gonane structure unsaturated in the 1,3,5(10),9(11) and 14-positions, selectively reducing in the B- and C-rings, and converting the aromatic A-ring compounds so-produced to gon-4-enes by Birch reduction and hydrolysis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 13732-69-9